GlassScriptPhysician profile
Sharon Rogoff
NPI 1235633512
$418.78
in general payments reported to CMS, 2019-2025
9 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.09 · 2023: $93.08 · 2024: $170 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $79.10 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $76.52 | 2024-2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $65.89 | 2024-2025 | Solosec, Phexx, Phexxi |
| Astellas Pharma US INC | $55.52 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $51.79 | 2023-2024 | Gardasil 9, Gardasil |
| Daiichi Sankyo INC. | $28.04 | 2023 | Injectafer |
| Sumitomo Pharma America, INC. | $24.83 | 2023 | Myfembree |
| Biogen, INC. | $19.13 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $17.96 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Rogoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.